- Pre-exposure prophylaxis (PrEP) is an antiviral drug for people at risk of HIV infection to prevent infection.
- Short-term users recommend taking the drug at least 3 days before and 3 days after exposed to the virus
- According to the clinical trial of iPrEx, a pre-exposure study, the results show that the infection rate can be reduced by 99% if they have a daily exposure to Truvada in men and men who have sexual contact with men.
You should consult a specialized medical professional before starting the treatment to assess your risk. If you require PEP urgently, please call 3160 4886/3162 0002 or email firstname.lastname@example.org as we are one of the few centres in Hong Kong that can provide you with this medication.